P022 Impaired clonogenic and proliferative potential of bone marrow mesenchymal stem cells in patients with myelodysplastic syndromesEmilia Stavroulaki, Helen Α. Papadaki, G. Gvazava et al.|Leukemia Research|2007Cited by 0
P-43 Effect of the treatment withCA2 anti-TNF monoclonal antibody on the bone marrow (BM) progenitor cell reserve and function and stromal cell function in patients with myelodysplastic syndrome (MDS). A study of the Greek mds study groupHelen Α. Papadaki, George D. Eliopoulos, Michalis Voulgarelis et al.|Leukemia Research|2005Cited by 0